Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CytomX Therapeutics

Explore full profile

Early-stage biotechnology company developing probodies, proteolytically-activated antibodies

South San Francisco, United StatesFounded 2008Biotech & Life Sciences
Valuation $331M Market cap · Aug/2026
Revenue $36M Latest reported FY

At a glance

Founded
2008
Headquarters
South San Francisco, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former CytomX Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

R1 TherapeuticsEst. 2025
Krishna PoluUnited States
Signal score88
EvolveImmune TherapeuticsEst. 2019
Charles FuchsUnited States
Signal score76
True North TherapeuticsEst. 2013
NSNancy StaglianoUnited States
Signal score60
SerImmuneEst. 2014
Patrick DaughertyUnited States
Signal score59
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States90%
🇮🇳 India6.9%
🇯🇵 Japan3.8%
🇬🇧 United Kingdom1.9%
🇭🇰 Hong Kong0%
Top 5 markets shown

Patents

Estimated portfolio value
$156M

80 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CytomX Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CytomX Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles